Trial Profile
A double-blind, randomized, placebo-controlled, crossover study for evaluation of tradipitant on response to oxycodone in humans
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Jul 2021
Price :
$35
*
At a glance
- Drugs Tradipitant (Primary) ; Oxycodone
- Indications Atopic dermatitis; COVID 2019 infections; Gastroparesis; Motion sickness; Pruritus
- Focus Therapeutic Use
- 31 Jul 2021 New trial record
- 01 Jul 2021 Results published in the Psychopharmacology